Search Within

Heather Jolie Landau

Formats
  1. Meeting Abstract (281)
  2. Journal Article (124)
  3. Research Letter (15)
  4. Book Section (5)
  5. Review (3)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (432)
  2. Center for Hematologic Malignancies (432)
  3. Department of Medicine (432)
  4. Hematologic Malignancies, Division of (432)
  5. Survivorship Research (432)
  6. Myeloma (246)

More Groups

People
  1. Sergio Giralt (260)
  2. Hani Hassoun (221)
  3. David Chung (206)
  4. Alexander Lesokhin (184)
  5. Gunjan Shah (161)
  6. Sham Mailankody (144)

More People

Years
  1. 2025 (10)
  2. 2024 (51)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (153)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Bone Marrow Transplantation (12)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (164)
  2. Elsevier Inc. (110)
  3. Nature Publishing Group (29)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (432)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Minimal residual disease (MRD) assessment before and after autologous hematopoietic cell transplantation (AutoHCT) and maintenance for multiple myeloma (MM): Results of the prognostic immunophenotyping for myeloma response (PRIMeR) study
    Meeting Abstract

    Hahn, T. E.; Wallace, P. K.; Fraser, R.; Fei, M.; Tario, J. D.; Howard, A.; Zhang, Y.; Blackwell, B.; Brunstein, C. G.; Efebera, Y. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity analysis of propylene glycol-free melphalan (Evomela®) compared to propylene glycol-based melphalan hydrochloride in autologous hematopoietic cell transplantation for multiple myeloma
    Meeting Abstract

    DeRespiris, L.; Bhatt, V.; Lin, A.; Maloy, M. A.; Chung, D. J.; Landau, H.; Scordo, M.; Giralt, S. A.; Shah, G. L.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Long term outcomes of high dose therapy and autologous hematopoietic cell transplant for lymphoplasmacytic lymphoma-associated systemic amyloidosis
    Meeting Abstract

    Bal, S.; Shah, G. L.; Hassoun, H.; Palomba, M. L.; Giralt, S. A.; Landau, H.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Genomic landscape of multiple myeloma with elevated lactate dehydrogenase
    Meeting Abstract

    Bal, S.; Girnius, S.; Starczynowski, D.; Landau, H.; Choi, K.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Clinical outcomes of newly diagnosed multiple myeloma patients with elevated lactate dehydrogenase who underwent autologous hematopoietic stem cell transplantation
    Meeting Abstract

    Bal, S.; Choi, K.; Oh, C.; Landau, H.; Starczynowski, D.; Girnius, S.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Primary results from the phase 3 TOURMALINE-AL1 trial of ixazomib-dexamethasone versus physician's choice of therapy in patients (Pts) with relapsed/refractory primary systemic AL amyloidosis (RRAL)
    Meeting Abstract

    Dispenzieri, A.; Kastritis, E.; Wechalekar, A. D.; Schönland, S. O.; Kim, K.; Sanchorawala, V.; Landau, H. J.; Kwok, F.; Suzuki, K.; Comenzo, R. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Comprehensive detection of recurring genomic abnormalities: A targeted sequencing approach for multiple myeloma
    Journal Article

    Yellapantula, V.; Hultcrantz, M.; Rustad, E. H.; Wasserman, E.; Londono, D.; Cimera, R.; Ciardiello, A.; Landau, H.; Akhlaghi, T.; Mailankody, S.; more...
    Blood Cancer Journal (2019)

    Fulltext@MSK | Save
  • BCMA expression in AL Amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D.; Dogan, A.; Giralt, S.; Hassoun, H.; Landau, H.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save